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Independent review of 4DCT scans used for SABR treatment planning
Abstract
2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on
behalf of American Association of Physicists in Medicine. Four-dimensional computerized tomography
(4DCT) is required for stereotactic ablative body radiotherapy (SABR) of mobile targets to account for
tumor motion during treatment planning and delivery. In this study, we report on the impact of an image
review quality assurance process performed prior to treatment planning by medical physicists for 4DCT
scans used for SABR treatment. Reviews were performed of 211 4DCT scans (193 patients) over a 3-yr
period (October 2014 to October 2017). Treatment sites included lung (n = 168), kidney/adrenal/adrenal
gland (n = 12), rib (n = 4), mediastinum (n = 10), liver (n = 2), T-spine (n = 1), and other abdominal sites (n =
14). It was found that in 23% (n = 49) of cases patient management was altered due to the review
process. The most frequent intervention involved patient-specific contouring advice (n = 35 cases, 17%)
including adjustment of internal target volume (ITV) margins. In 13 cases (6%) a rescan was requested
due to extensive motion artifact rendering the scan inadequate for SABR treatment planning. 4DCT review
by medical physicists was found to be an effective method to improve plan quality for SABR.
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Abstract
Four‐dimensional computerized tomography (4DCT) is required for stereotactic abla-
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tive body radiotherapy (SABR) of mobile targets to account for tumor motion during
treatment planning and delivery. In this study, we report on the impact of an image
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review quality assurance process performed prior to treatment planning by medical
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211 4DCT scans (193 patients) over a 3‐yr period (October 2014 to October 2017).
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physicists for 4DCT scans used for SABR treatment. Reviews were performed of
Treatment sites included lung (n = 168), kidney/adrenal/adrenal gland (n = 12), rib
(n = 4), mediastinum (n = 10), liver (n = 2), T‐spine (n = 1), and other abdominal sites
(n = 14). It was found that in 23% (n = 49) of cases patient management was
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altered due to the review process. The most frequent intervention involved patient‐
speciﬁc contouring advice (n = 35 cases, 17%) including adjustment of internal target volume (ITV) margins. In 13 cases (6%) a rescan was requested due to extensive
motion artifact rendering the scan inadequate for SABR treatment planning. 4DCT
review by medical physicists was found to be an effective method to improve plan
quality for SABR.
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1 | INTRODUCTION

the breathing cycle. From the tumor motion in the individual phases,
one can generate an internal target volume (ITV) which encompasses

Stereotactic ablative body radiotherapy (SABR) is characterized by

the GTV as well as its motion. Due to the risk of artifacts in 4DCTs,

high radiation doses delivered in one or few treatment fractions.

our institution has adopted a policy that these scans are reviewed

SABR has been shown to be safe and effective for patients with

by a medical physicist prior to treatment planning to ensure that the

early‐stage non‐small cell lung cancer1–3 and kidney cancer,4,5 and

image is suitable for approximation of the tumor motion due to res-

shown promise for liver,6,7 spine8 and oligometastatic disease,9,10 as

piration as well as for the creation of a reasonable reference image

well as pancreas and prostate,11 in select patients. SABR treatment

for image guidance. Ideally, the ITV contour must encompass the

requires image guidance for accurate delivery, particularly for mobile

size of the tumor as well as its full excursion throughout the entire

targets. Patient immobilization and motion management strategies

respiratory cycle.

are used to ensure treatment is delivered as planned. For mobile tar-

Irregular breathing patterns or 4DCT reconstruction errors such

gets, retrospectively binned 4D‐computed tomography (4DCT) scans

as one phase not reconstructing properly may lead to systematic

may be performed to generate volumetric images at each phase of

errors in ITV delineation propagating through the treatment chain
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which may not be obvious upon reviewing the maximum intensity

used however if irregular breathing was noted during the surview

projection (MIP) or average scans alone. Recently the European

scan, radiation therapists would pause the scan procedure to provide

Organisation for Research and Treatment of Cancer (EORTC) multi-

basic coaching, although some patients still could not breath regu-

centre Lungtech trial reported on the results of RTQA activities for

larly throughout the entire scan. The resulting respiratory trace was

4DCT across 11 centers. Large deviations in contour volume of up

used for phase binning, creating 10 phases of the breathing cycle.

to 99% were found across different sites despite imaging the same

Maximum intensity projection (MIP) and average datasets, which are

phantom under the same motion pattern.12 The effects of irregular

used for ITV delineation and dose calculation, respectively, were

breathing patterns on ITV delineation of moving targets in the con-

reconstructed from the raw data. The MIP was used for ITV delin-

text of lung SABR have been described by Clements et al.13 who

eation. 4DCT scans were reviewed by a medical physicist prior to

demonstrated erroneous ITV delineation using MIP images for mov-

treatment planning. Review was performed on the CT console, using

ing targets with large amplitude undergoing irregular motion pat-

the PulmoViewer application. This application allows visualization of

terns. Similar ﬁndings have been reported by Park et al.

14

who

the breathing trace with the 4DCT image data, as well as tools to

determined that the MIP underestimated the true target motion in

determine the corresponding breath at each superior‐inferior scan

the case of irregular motion. Measured PTV dose discrepancies of

location. Tumor motion was measured using the ruler tool provided

greater than 10% were reported by Huang et al.15 for irregular

in PulmoViewer to assess the maximum displacement of the lesion

motion patterns in a moving phantom for targets with large excur-

between maximum inhale and exhale phases. The tumor boundaries

sions, demonstrating systematic under‐dose of the PTV periphery in

were identiﬁed using the radiation oncologists contour when avail-

such cases. Clinical consequences may be severe, since systematic

able, or through diagnostic imaging in consultation with radiation

PTV under‐dosing from inappropriate ITV delineation will result in

oncologists. A single, well‐deﬁned edge of the tumor on each phase

compromised tumor control probability. This risk is heightened in the

was used to determine motion, therefore this is an estimate of

superior‐inferior direction for co‐planar ﬁeld deliveries where the

tumor motion rather than the motion of the centre of mass. Choice

dose falloff is steepest. Therefore, it is essential that the appropriate-

of tumor edge was at the discretion of the reviewing physicist and

ness of all 4DCT imaging be veriﬁed prior to clinical use to ensure

was case‐speciﬁc, though usually the inferior‐most aspect of the

that images derived are a true representation of the full tumor

lesion was chosen if well‐deﬁned. If the 4DCT was deemed by the

excursion, particularly in cases of irregular breathing.

medical physicist to not be an accurate representation of tumor

This study presents the ﬁndings of independent, prospective

motion, advice was provided on whether to rescan the patient or

reviews performed by radiation oncology medical physicists of 211

adjust planning target volume (PTV) margins to account for increased

patient 4DCT scans acquired for SABR pretreatment planning in a

uncertainty, along with an estimate of the uncertainty.

large radiotherapy centre. We report on the frequency of required

4D‐computed tomography review data were collected from three

intervention as a result of the review process and correlation with

radiotherapy facilities across our institution over a 3‐yr period

regularity of patient breathing trace.

between October 2014 and October 2017. Outcomes of the 4DCT
reviews were assessed and each patient breathing trace were classiﬁed according to regularity. Respiration cycles were classiﬁed as

2 | MATERIALS AND METHODS

either “regular”, “adequate”, or “irregular”. For a breathing trace to
be considered “regular”, the breathing pattern had to be consistent,

Review guidelines for 4DCT image sets were developed based on
16

commissioning work

and experiences from quality assurance for

repetitive in its amplitude and frequency, and free of signiﬁcant
irregularities, such as a halt in breathing or considerable change in

several clinical trials.17,18 An in‐house training programme was devel-

breathing pattern. “Adequate” scans contained some irregularities,

oped for medical physicists to establish a minimum skillset for per-

such as a change in breathing pattern, but not affecting the tumor

forming 4DCT reviews in the context of SABR. A patient‐speciﬁc

level. “Irregular” scans contained considerable irregularity in breath-

review checklist was designed to aid in the review process and facili-

ing pattern at some point during scanning level of tumor excursion,

tate data collection, which has been provided as supplementary

or a change in breathing at the tumor level severe enough such that

material.

the subsequent image would not fully capture the tumor motion.

4D‐computed tomography scans were acquired on a Brilliance

Examples of “irregular” breathing traces at the tumor level are shown

widebore 16‐slice scanner (Philips Medical Systems, Eindhoven, the

in Fig. 1. Breathing classiﬁcation was made qualitatively, based on

Netherlands) using retrospective gating with a gantry rotation period

the judgment of the reviewing medical physicist. Additionally, the

of 0.44 s, 140 kVp and a pitch adjusted based on the breathing rate

tumor size and motion was documented for each case, including

with a resulting patient dose approximately twice the one of a 3D

whether hysteresis was evident in the tumor excursion throughout

scan.19 4DCT was also performed for lesions where dose calculation

the respiratory cycle. Hysteresis was determined by observation of

was likely to be affected by surrounding mobile structures, such as

tumor motion on all phases viewed on the sagittal plane. Tumor

ribs and lower thoracic spine at the level of the diaphragm. Respira-

motion in the anterior‐posterior direction as well as superior‐inferior

tion was monitored using the Philips bellows system afﬁxed to the

was classiﬁed as containing hysteresis. Reported CT dose index

patients’ abdomen.20 Audio or visual coaching was not routinely

(CTDI), pitch and breathing rates were also recorded. Breathing rates

|
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(a)

3

(b)

F I G . 1 . Examples showing irregular
breathing in the case of (a) breathing
stopped during scanning at the tumor
level, and (b) irregular breath at the tumor
level despite otherwise regular breathing.
The cross‐hairs indicate that the tumor and
the arrows mark the breathing track at the
tumor level

were measured using the tool provided in the PulmoView software,

140

which reports both the average and location‐speciﬁc breathing rate
as chosen by the user. The outcomes from each review regarding

120

patient management were also assessed.

100

Between October 2014 and October 2017, a total of 597 patients
scanned with 4DCT were treated using SABR. Of those, 211 4DCT

number of patients

3 | RESULTS

no issues (n=162)
advice on margins or contouring (n=36)
re-scan (n=13)
80
60
40
20

scan records were available for this retrospective audit. Target locations included lung (n = 168), kidney/adrenal/adrenal gland (n = 12),
rib (n = 4), mediastinum (n = 10), liver (n = 2), T‐spine (n = 1) and

0
regular

other abdominal sites (n = 14). Review of 4DCT scans required
approximately 20 min of medical physicists’ time per patient. As the
SABR programme increased capacity, the number of 4DCT reviews
was found to steadily increase.
The number of patient breathing traces which were considered
“regular”, “adequate” or “irregular” is shown in Fig. 2. The impact on

adequate

irregular

breathing trace classification

F I G . 2 . Distribution of patient breathing traces according to
respiratory cycle regularity for 211 SABR patients. Change in patient
management as a result of 4DCT review is indicated by the shaded
bars. A total of 49 cases (23%) required change in patient
management. Of those, 25 (51%) were classiﬁed as ‘adequate’ or
‘irregular’ breathing

patient management for each category is also shown. No issues
were found for 162 patients (77%) and the scans were used for
SABR treatment planning without intervention. Of those 162
patients, 136 (84%) had regular breathing patterns, 19 (12%) had
adequate regularity and 7 (4%) were considered irregular. For
remaining cases (n = 49, 23%), 4DCT reviews revealed issues with
the ﬁnal images and required intervention. A re‐scan was subsequently requested in 13 cases (6%) due to excessive motion artifact
rendering the ﬁnal images unsuitable for ITV delineation for SABR
treatment planning. For remaining cases (n = 35, 17%), advice to use
modiﬁed margins in ITV delineation or other contouring advice
including fusion of staging images such as PET was provided to compensate for deﬁciencies in the 4DCT scan based on advice from the
reviewing medical physicist.
Figure 3 shows the average breathing rate throughout the 4DCT
scan and recorded breathing rate at the tumor level, with data
grouped according to intervention type. The line of identity is shown

breathing rate throughout the scan did not necessarily predict intervention requirements.
The amplitude of total tumor motion is shown in Fig. 4 as a
function of breathing rate at the tumor level, with data grouped
according to intervention requirements. Tumors with motion less
than 3 mm did not require intervention regardless of breathing rate.
Large tumor excursion or rapid breathing rate were not predictors
for intervention.
Table 1 shows the frequency of tumor hysteresis throughout the
respiratory cycle. Hysteresis was observed in 30% of patients in this
study and is often noted for inferiorly located lesions close to the
posterior chest wall.
Comments in the review form were reviewed to determine the
cause of the artifacts. A number of common causes were identiﬁed:
1. The patient’s breathing was highly irregular, leading to poor

by a solid line with a ±10% margin indicated by the dashed lines. It

tumor deﬁnition in any one phase, and insufﬁcient quality to

can be seen that breathing rate at the tumor level compared to

determine range of tumor motion.

4
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T A B L E 1 Summary cases involving tumor hysteresis. Hysteresis
was observed in 64 out of 211 4DCT scans (30%). For the 48 cases
requiring some change in patient management, 23 cases (48%) were
observed to have tumor hysteresis compared with 41 out of 163
(25%) of cases where no intervention was required

breathing rate at tumour level (BPM)

35
no issues
advice on margin or contouring
re-scan

25

Re‐scan or
advice

No issues
Hysteresis
Yes/Slight

15

No

n

%

n

%

41

25

23

48

122

75

25

52

expiration (inspiration) not being recorded, i.e., lack of informa-

5
5

15

25

35

average breathing rate (BPM)

tion on either end of the tumor excursion.
6. The patient had an unintended deep inspiration while the tumor

F I G . 3 . Correlation between average breathing rate throughout
the 4DCT scan duration and breathing rate at the tumor level. The
solid line represents the line of identity and the dashed lines
represent ± 10% variation

was moving through the scanning plane, leading to overestimation of tumor motion
Reasons for physics consultations other than due to breathing
irregularity and motion estimation included overestimation of the

breathing rate at tumour level (BPM)

40

required tube current by the scanner software, slow breathing patno issues
advice on margins or contouring
re-scan

terns (<10 bpm not allowing 4DCT acquisition), inaccurate detection
of inhale peaks by the scanner software and poor image quality.

30

4 | DISCUSSION
20

This study reports on the outcomes of independent review for
patient 4DCT scans acquired for treatment of SABR to mobile tar10

gets. The aim of these reviews was to determine if each scan was a
reasonable representation of tumor motion throughout the breathing
cycle and was appropriate for the purposes of SABR treatment plan-

0
0

10

20

30

40

total tumour amplitude [mm]

ning, including target (ITV) delineation and dose calculation.
One limitation of this study is the subjectiveness amongst different physicists in performing quantitative analysis of patient 4DCT

F I G . 4 . Change in patient management is shown relative to tumor
amplitude and patient breathing rate (breaths per minute, BPM) at
the tumor level. Motion less than 3 mm required no intervention.
Breathing rate was not a predictor for intervention requirements

reviews. While training was provided to harmonize interpretation,
there is still a degree of subjectiveness in the review process. Nevertheless, intervention was required in 23% of all reviewed cases.
Irregular breathing rate was found to be a contributor to inadequate
scans (16% of regular breathing traces requiring intervention com-

2. The patient was breathing regularly, but coughed during the
acquisition

pared to 57% of scans classiﬁed as “irregular”, Fig. 2). One common
problem was identiﬁed as inappropriate choice of scan pitch. Scan-

3. Patient was breathing regularly, but while the tumor was moving

ner pitch is adjusted based on patient breathing rate prior to com-

through the scanning plane the patient stopped breathing, lead-

mencing a scan. A lower pitch is required to maximize the chance of

ing to the tumor appearing artiﬁcially stationary, with anatomy

fully capturing tumor motion in the case of slower breathing rates.

superior and inferior moving with respiration.

The pitch is selected after the patient has spent some time in quiet

4. Patient’s breathing continuously slowed down from initial scan

breathing and is monitored up until commencing a scan. However,

pitch setting to acquisition. This may have been due to medica-

upon commencing a scan it was found in some cases that a patient

tion to relax the patient for the scan

breathing rate can change, even throughout the duration of the scan.

5. The patient did not exhale (or inhale) fully, while scanning

In some cases the breathing stopped completely while scanning

through the superior (or inferior) aspect of the tumor. This

through the level of the lesion, resulting in no visible tumor motion.

resulted in the superior (or inferior) aspect of the tumor at full

In such cases a rescan is required which usually addressed concerns

|
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raised in the ﬁrst scan, unless a similar interruption in breathing pat-

ITVs based on respiratory‐gated 4DCT are therefore necessary for

tern occurred. In some cases irregular breathing was noted during

improving target deﬁnition.25 The additional anterior‐posterior and

the scan but no intervention was required. This may be due to the

left‐right motion requires careful consideration of each phase of the

irregularity occurring at anatomical locations away from the target

breathing cycle, since the maximum inhale and maximum exhale may

region. In such cases, irregular breathing is noted but if the target

not capture the intermediate motion patterns. Use of the maximum

region is unaffected intervention is not warranted. Since changes in

intensity projection (MIP) image or all individual phases for ITV delin-

breathing rate were shown to be a signiﬁcant contributor to motion

eation ensures tumors with hysteresis are fully captured.

artifacts in our centre, radiation therapists have subsequently begun
monitoring the respiratory trace closely during a scan. If irregular
breathing is indicated during a scan, a physicist is called to review

5 | CONCLUSIONS

the respiratory trace while the patient is still on‐site. This facilitates
more timely re‐scans where warranted without the need to call a

Patient‐speciﬁc 4DCT reviews by a medical physicist was shown to

patient back to hospital.

have a signiﬁcant impact on patient management in a large cohort of

Figure 1 shows that both large [Fig. 1(a)] and quite subtle

patients treated with SABR to moving lesions with a high interven-

[Fig. 1(b)] irregularities can impact on motion assessment. Both

tion rate of 23% of all cases. Irregular breathing patterns during

breathing frequency and amplitude can have a detrimental impact.

4DCT scans were shown to cause artefacts which may impact on

Through the examples shown in this study, amplitude can have a

the resulting ITV contours, hence treatment ﬁelds. In 23% of cases

major impact if the tumor isn’t moving its “normal” extent during

the physicist was able to advise on margins to accommodate for lost

acquisition then tumor motion will not be sufﬁciently captured.

motion during the scan, while in other cases a rescan was required.

However, irregularities in frequency also impact our assessment due

Tumor hysteresis was noted in 30% of scans, requiring careful

to discontinuity artifacts, which is often inter‐related to image acqui-

review of all phases to ensure tumor excursion is fully captured in all

sition parameters such as pitch factor and gantry speed. It is thus

directions of motion. Results from this study suggest patient‐speciﬁc

quite challenging to quantify respiratory trace irregularities in a man-

4DCT QA should be a mandatory part of a patient’s treatment path-

ner that can be applied routinely in the clinic. Thus, ongoing patient‐

way in SABR treatments of moving targets to ensure motion is ade-

speciﬁc reviews are required.

quately captured for the purposes of motion management and

Typically a 4DCT scan acquires images of each anatomical slice

treatment planning.

for the duration of one to two breaths. Just one irregular breath can
therefore distort the resulting image at a given anatomical slice.
Review of PET scans (if available) acquired over several minutes was
used to augment the relevant information where necessary. Also the
CBCT, or 4D‐CBCT if available, on the ﬁrst treatment day can be
used to validate the motion estimates. 4D cone‐beam CTs were
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occasionally acquired to evaluate motion, as these are more robust
to breathing irregularity due to the whole anatomy being imaged for
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pled with the sampling frequency, the treatment respiratory motion
is underestimated in 4DCTs.21 This means that any underestimation
of the motion from 4DCTs is potentially more signiﬁcant relative to
treatment motion.
Tumor hysteresis was noted in 30% of cases (n = 64). Of those,
48% required intervention compared to 25% of cases without hysteresis. Although this study is not powered to compare intervention
rates with and without tumor hysteresis the differences are worth
noting. It may be that a more complex motion pattern has a higher
chance of being missed in the presence of artifacts, compared to a
more simple superior/inferior motion pattern.
Earlier studies suggest that artifacts in 4DCT are common and
associated with breathing irregularity.22 Patient training, coaching
and feedback would be helpful to improve patient compliance with
regular and reproducible breathing.23 Furthermore, thoracic lesions
are subject to often complex motion patterns depending on the location and can even be affected by cardiac motion.24 Individualized
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